Transcatheter Pulmonary Valve Market Size, Share & Trends Report

Transcatheter Pulmonary Valve Market Size, Share & Trends Analysis Report By Application (Cardiac Anomaly, Pulmonary Atresia, Pulmonary Stenosis, Pulmonary Regurgitation, Tetralogy Of Fallot, Truncus Arteriosus), And Segment Forecasts, 2018 - 2025

  • Report ID: GVR-1-68038-702-5
  • Number of Pages: 137
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2016
  • Industry: Healthcare

Market Segmentation

  • Transcatheter Pulmonary Valve Application Outlook (Revenue, USD Million; 2014 - 2025)
    • Cardiac Anomaly
    • Pulmonary Atresia
    • Pulmonary Stenosis
    • Pulmonary Regurgitation
    • Tetralogy of Fallot
    • Truncus Arteriosus
    • Others
  • Transcatheter Pulmonary Valve Technology Outlook (Revenue, USD Million; 2014 - 2025)
    • Balloon-Expanded Transcatheter Valve
    • Self-Expanded Transcatheter Valve
  • Transcatheter Pulmonary Valve End-Use Outlook (Revenue, USD Million; 2014 - 2025)
    • Adult
    • Pediatric
  • Transcatheter Pulmonary Valve Raw Material Outlook (Revenue, USD Million; 2014 - 2025)
    • Synthetic Transcatheter Valve
    • Tissue Engineered Transcatheter Valve
  • Transcatheter Pulmonary Valve Regional Outlook (Revenue, USD Million, 2014 - 2025)
    • North America
      • The U.S.
        • U.S. Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Cardiac Anomaly
          • Pulmonary Atresia
          • Pulmonary Stenosis
          • Pulmonary Regurgitation
          • Tetralogy of Fallot
          • Truncus Arteriosus
          • Others
        • U.S. Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • Balloon-Expanded Transcatheter Valve
          • Self-Expanded Transcatheter Valve
        • U.S. End-Use Outlook (Revenue, USD Million, 2014 - 2025)
          • Adult
          • Pediatric
        • U.S. Raw Material Outlook (Revenue, USD Million, 2014 - 2025)
          • Synthetic Transcatheter Valve
          • Tissue Engineered Transcatheter Valve
      • Canada
        • Canada Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Cardiac Anomaly
          • Pulmonary Atresia
          • Pulmonary Stenosis
          • Pulmonary Regurgitation
          • Tetralogy of Fallot
          • Truncus Arteriosus
          • Others
        • Canada Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • Balloon-Expanded Transcatheter Valve
          • Self-Expanded Transcatheter Valve
        • Canada End-Use Outlook (Revenue, USD Million, 2014 - 2025)
          • Adult
          • Pediatric
        • Canada Raw Material Outlook (Revenue, USD Million, 2014 - 2025)
          • Synthetic Transcatheter Valve
          • Tissue Engineered Transcatheter Valve
    • Europe
      • UK
        • UK Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Cardiac Anomaly
          • Pulmonary Atresia
          • Pulmonary Stenosis
          • Pulmonary Regurgitation
          • Tetralogy of Fallot
          • Truncus Arteriosus
          • Others
        • UK Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • Balloon-Expanded Transcatheter Valve
          • Self-Expanded Transcatheter Valve
        • UK End-Use Outlook (Revenue, USD Million, 2014 - 2025)
          • Adult
          • Pediatric
        • UK Raw Material Outlook (Revenue, USD Million, 2014 - 2025)
          • Synthetic Transcatheter Valve
          • Tissue Engineered Transcatheter Valve
      • Germany
        • Germany Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Cardiac Anomaly
          • Pulmonary Atresia
          • Pulmonary Stenosis
          • Pulmonary Regurgitation
          • Tetralogy of Fallot
          • Truncus Arteriosus
          • Others
        • Germany Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • Balloon-Expanded Transcatheter Valve
          • Self-Expanded Transcatheter Valve
        • Germany End-Use Outlook (Revenue, USD Million, 2014 - 2025)
          • Adult
          • Pediatric
        • Germany Raw Material Outlook (Revenue, USD Million, 2014 - 2025)
          • Synthetic Transcatheter Valve
          • Tissue Engineered Transcatheter Valve
      • Spain
        • Spain Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Cardiac Anomaly
          • Pulmonary Atresia
          • Pulmonary Stenosis
          • Pulmonary Regurgitation
          • Tetralogy of Fallot
          • Truncus Arteriosus
          • Others
        • Spain Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • Balloon-Expanded Transcatheter Valve
          • Self-Expanded Transcatheter Valve
        • Spain End-Use Outlook (Revenue, USD Million, 2014 - 2025)
          • Adult
          • Pediatric
        • Spain Raw Material Outlook (Revenue, USD Million, 2014 - 2025)
          • Synthetic Transcatheter Valve
          • Tissue Engineered Transcatheter Valve
      • Russia
        • Russia Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Cardiac Anomaly
          • Pulmonary Atresia
          • Pulmonary Stenosis
          • Pulmonary Regurgitation
          • Tetralogy of Fallot
          • Truncus Arteriosus
          • Others
        • Russia Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • Balloon-Expanded Transcatheter Valve
          • Self-Expanded Transcatheter Valve
        • Russia End-Use Outlook (Revenue, USD Million, 2014 - 2025)
          • Adult
          • Pediatric
        • Russia Raw Material Outlook (Revenue, USD Million, 2014 - 2025)
          • Synthetic Transcatheter Valve
          • Tissue Engineered Transcatheter Valve
      • France
        • France Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Cardiac Anomaly
          • Pulmonary Atresia
          • Pulmonary Stenosis
          • Pulmonary Regurgitation
          • Tetralogy of Fallot
          • Truncus Arteriosus
          • Others
        • France Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • Balloon-Expanded Transcatheter Valve
          • Self-Expanded Transcatheter Valve
        • France End-Use Outlook (Revenue, USD Million, 2014 - 2025)
          • Adult
          • Pediatric
        • France Raw Material Outlook (Revenue, USD Million, 2014 - 2025)
          • Synthetic Transcatheter Valve
          • Tissue Engineered Transcatheter Valve
      • Italy
        • Italy Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Cardiac Anomaly
          • Pulmonary Atresia
          • Pulmonary Stenosis
          • Pulmonary Regurgitation
          • Tetralogy of Fallot
          • Truncus Arteriosus
          • Others
        • Italy Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • Balloon-Expanded Transcatheter Valve
          • Self-Expanded Transcatheter Valve
        • Italy End-Use Outlook (Revenue, USD Million, 2014 - 2025)
          • Adult
          • Pediatric
        • Italy Raw Material Outlook (Revenue, USD Million, 2014 - 2025)
          • Synthetic Transcatheter Valve
          • Tissue Engineered Transcatheter Valve
    • Asia Pacific
      • Japan
        • Japan Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Cardiac Anomaly
          • Pulmonary Atresia
          • Pulmonary Stenosis
          • Pulmonary Regurgitation
          • Tetralogy of Fallot
          • Truncus Arteriosus
          • Others
        • Japan Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • Balloon-Expanded Transcatheter Valve
          • Self-Expanded Transcatheter Valve
        • Japan End-Use Outlook (Revenue, USD Million, 2014 - 2025)
          • Adult
          • Pediatric
        • Japan Raw Material Outlook (Revenue, USD Million, 2014 - 2025)
          • Synthetic Transcatheter Valve
          • Tissue Engineered Transcatheter Valve
      • China
        • China Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Cardiac Anomaly
          • Pulmonary Atresia
          • Pulmonary Stenosis
          • Pulmonary Regurgitation
          • Tetralogy of Fallot
          • Truncus Arteriosus
          • Others
        • China Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • Balloon-Expanded Transcatheter Valve
          • Self-Expanded Transcatheter Valve
        • China End-Use Outlook (Revenue, USD Million, 2014 - 2025)
          • Adult
          • Pediatric
        • China Raw Material Outlook (Revenue, USD Million, 2014 - 2025)
          • Synthetic Transcatheter Valve
          • Tissue Engineered Transcatheter Valve
      • Hong Kong
        • Hong Kong Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Cardiac Anomaly
          • Pulmonary Atresia
          • Pulmonary Stenosis
          • Pulmonary Regurgitation
          • Tetralogy of Fallot
          • Truncus Arteriosus
          • Others
        • Hong Kong Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • Balloon-Expanded Transcatheter Valve
          • Self-Expanded Transcatheter Valve
        • Hong Kong End-Use Outlook (Revenue, USD Million, 2014 - 2025)
          • Adult
          • Pediatric
        • Hong Kong Raw Material Outlook (Revenue, USD Million, 2014 - 2025)
          • Synthetic Transcatheter Valve
          • Tissue Engineered Transcatheter Valve
      • Taiwan
        • Taiwan Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Cardiac Anomaly
          • Pulmonary Atresia
          • Pulmonary Stenosis
          • Pulmonary Regurgitation
          • Tetralogy of Fallot
          • Truncus Arteriosus
          • Others
        • Taiwan Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • Balloon-Expanded Transcatheter Valve
          • Self-Expanded Transcatheter Valve
        • Taiwan End-Use Outlook (Revenue, USD Million, 2014 - 2025)
          • Adult
          • Pediatric
        • Taiwan Raw Material Outlook (Revenue, USD Million, 2014 - 2025)
          • Synthetic Transcatheter Valve
          • Tissue Engineered Transcatheter Valve
    • Latin America
      • Brazil
        • Brazil Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Cardiac Anomaly
          • Pulmonary Atresia
          • Pulmonary Stenosis
          • Pulmonary Regurgitation
          • Tetralogy of Fallot
          • Truncus Arteriosus
          • Others
        • Brazil Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • Balloon-Expanded Transcatheter Valve
          • Self-Expanded Transcatheter Valve
        • Brazil End-Use Outlook (Revenue, USD Million, 2014 - 2025)
          • Adult
          • Pediatric
        • Brazil Raw Material Outlook (Revenue, USD Million, 2014 - 2025)
          • Synthetic Transcatheter Valve
          • Tissue Engineered Transcatheter Valve
      • Mexico
        • Mexico Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Cardiac Anomaly
          • Pulmonary Atresia
          • Pulmonary Stenosis
          • Pulmonary Regurgitation
          • Tetralogy of Fallot
          • Truncus Arteriosus
          • Others
        • Mexico Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • Balloon-Expanded Transcatheter Valve
          • Self-Expanded Transcatheter Valve
        • Mexico End-Use Outlook (Revenue, USD Million, 2014 - 2025)
          • Adult
          • Pediatric
        • Mexico Raw Material Outlook (Revenue, USD Million, 2014 - 2025)
          • Synthetic Transcatheter Valve
          • Tissue Engineered Transcatheter Valve
    • MEA
      • South Africa
        • South Africa Application Outlook (Revenue, USD Million, 2014 - 2025)
          • Cardiac Anomaly
          • Pulmonary Atresia
          • Pulmonary Stenosis
          • Pulmonary Regurgitation
          • Tetralogy of Fallot
          • Truncus Arteriosus
          • Others
        • South Africa Technology Outlook (Revenue, USD Million, 2014 - 2025)
          • Balloon-Expanded Transcatheter Valve
          • Self-Expanded Transcatheter Valve
        • South Africa End-Use Outlook (Revenue, USD Million, 2014 - 2025)
          • Adult
          • Pediatric
        • South Africa Raw Material Outlook (Revenue, USD Million, 2014 - 2025)
          • Synthetic Transcatheter Valve
          • Tissue Engineered Transcatheter Valve

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2014 to 2025
  • Market estimates and forecast for product segments up to 2025
  • Regional market size and forecast for product segments up to 2025
  • Market estimates and forecast for application segments up to 2025
  • Regional market size and forecast for application segments up to 2025
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon